Skip to main content

Table 1 Annual consumption of erythropoietin and intravenous iron according Paricalcitol and Calcitriol therapies

From: Budget impact of secondary hyperparathyroidism treatment in chronic kidney disease in an Ecuadorian social security hospital

Parameter Paricalcitol Calcitriol P-value
Erythropoietin Weekly Average Consumption 11,758 UI 13,930 UI <0.05
Intravenous Iron Weekly Average Consumption 59 mg 45 mg <0.05
  1. Source: Capuano, A., 2009